Amesite Inc. Receives Nasdaq Listing Deficiency Notice

On October 28, 2025, Amesite Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The letter notified the company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The company also failed to meet alternative listing standards, including a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year. Amesite has 45 calendar days to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days. The company intends to take all reasonable measures to regain compliance but cannot guarantee success. The deficiency letter does not immediately affect the listing or trading of the company’s common shares, which will continue to trade under the symbol 'AMST'.